Joe Ramos to Neoplasm Invasiveness
This is a "connection" page, showing publications Joe Ramos has written about Neoplasm Invasiveness.
Connection Strength
0.261
-
Sulzmaier FJ, Young-Robbins S, Jiang P, Geerts D, Prechtl AM, Matter ML, Kesari S, Ramos JW. RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics. Oncotarget. 2016 Nov 29; 7(48):79869-79884.
Score: 0.132
-
Sulzmaier FJ, Ramos JW. RSK isoforms in cancer cell invasion and metastasis. Cancer Res. 2013 Oct 15; 73(20):6099-105.
Score: 0.106
-
Liang Z, Sorribas A, Sulzmaier FJ, Jim?nez JI, Wang X, Sauvage T, Yoshida WY, Wang G, Ramos JW, Williams PG. Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits. J Org Chem. 2011 May 20; 76(10):3635-43.
Score: 0.022